Literature DB >> 19647113

Novel endogenous N-acyl glycines identification and characterization.

Heather B Bradshaw1, Neta Rimmerman, Sherry S-J Hu, Sumner Burstein, J Michael Walker.   

Abstract

Discovery of the endogenous cannabinoid and N-acyl amide, anandamide (N-arachidonoyl ethanolamine), paved the way for lipidomics discoveries in the growing family of N-acyl amides. Lipidomics is a field that is broadening our view of the molecular world to include a wide variety of endogenous lipid signaling molecules. Many of these lipids will undoubtedly provide new insights into old questions while others will provide broad platforms for new questions. J Michael Walker's last 8 years were dedicated to this search and he lived long enough to see 54 novel lipids isolated from biological tissues in his laboratory. Here, we summarize the biosynthesis, metabolism and biological activity of two of the family of N-acyl glycines, N-arachidonoyl glycine and N-palmitoyl glycine, and introduce four additional members: N-stearoyl glycine, N-linoleoyl glycine, N-oleoyl glycine, and N-docosahexaenoyl glycine. Each of these compounds is found throughout the body at differing levels suggesting region-specific functionality and at least four of the N-acyl glycines are regulated by the enzyme fatty acid amide hydrolase. The family of N-acyl glycines presented here is merely a sampling of what is to come in the continuing discovery of novel endogenous lipids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647113     DOI: 10.1016/S0083-6729(09)81008-X

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  44 in total

1.  N-acyl taurines are anti-proliferative in prostate cancer cells.

Authors:  Vicky Chatzakos; Katharina Slätis; Tatjana Djureinovic; Thomas Helleday; Mary C Hunt
Journal:  Lipids       Date:  2011-12-11       Impact factor: 1.880

2.  Reversible lysine acetylation regulates activity of human glycine N-acyltransferase-like 2 (hGLYATL2): implications for production of glycine-conjugated signaling molecules.

Authors:  Dominik P Waluk; Filip Sucharski; Laszlo Sipos; Jerzy Silberring; Mary C Hunt
Journal:  J Biol Chem       Date:  2012-03-09       Impact factor: 5.157

Review 3.  N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets.

Authors:  Mark Connor; Chris W Vaughan; Robert J Vandenberg
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

4.  Evidence for a GPR18 Role in Chemotaxis, Proliferation, and the Course of Wound Closure in the Cornea.

Authors:  Natalia Murataeva; Laura Daily; Xavier Taylor; Amey Dhopeshwarkar; Sherry Shu-Jung Hu; Sally Miller; Douglas McHugh; Olivia Oehler; Shimin Li; Joseph A Bonanno; Ken Mackie; Alex Straiker
Journal:  Cornea       Date:  2019-07       Impact factor: 2.651

Review 5.  GPR18 in microglia: implications for the CNS and endocannabinoid system signalling.

Authors:  D McHugh
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

6.  Δ9-Tetrahydrocannabinol changes the brain lipidome and transcriptome differentially in the adolescent and the adult.

Authors:  Emma Leishman; Michelle Murphy; Ken Mackie; Heather B Bradshaw
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-02-08       Impact factor: 4.698

Review 7.  A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation.

Authors:  Rita Scarpelli; Oscar Sasso; Daniele Piomelli
Journal:  ChemMedChem       Date:  2015-10-21       Impact factor: 3.466

8.  Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain.

Authors:  Emma Leishman; Ken Mackie; Serge Luquet; Heather B Bradshaw
Journal:  Biochim Biophys Acta       Date:  2016-03-05

9.  Functional metagenomic discovery of bacterial effectors in the human microbiome and isolation of commendamide, a GPCR G2A/132 agonist.

Authors:  Louis J Cohen; Hahk-Soo Kang; John Chu; Yun-Han Huang; Emma A Gordon; Boojala Vijay B Reddy; Melinda A Ternei; Jeffrey W Craig; Sean F Brady
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

10.  Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma.

Authors:  Jodianne T Wood; John S Williams; Lakshmipathi Pandarinathan; David R Janero; Carol J Lammi-Keefe; Alexandros Makriyannis
Journal:  J Lipid Res       Date:  2010-01-13       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.